Food and Drug Regulation

FDA should take steps to strengthen the regenerative medicine industry.

Edible insects may become essential in the wake of the COVID-19 crisis, but FDA regulation is lacking.

A federal task force proposes regulatory solutions to mitigate drug shortages.

FDA warns consumers that the agency has not evaluated most CBD products and cannot say they are safe.

Unlike new drugs and devices, combination products may fall through the regulatory cracks.

The FTC and Justice Department must change their interpretation of antitrust laws to protect fair competition in agriculture.

Scholar argues that FDA can, and should, regulate marijuana edibles.

Scholar argues for promotion of environmentally conscious plant-based diets through regulation.

As the United States struggles with opioid addiction, litigation rages over medically supervised consumption facilities.

Scholar says that human milk should be regulated to ensure donor milk is safe, accessible, and affordable.

Better oversight is needed of the “biohacking” that individuals perform on themselves.

Scholar argues that the association between cosmetics and femininity has contributed to harmful under-regulation.